These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11722649)

  • 1. All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity.
    DeCicco KL; Youngdahl JD; Ross AC
    Immunology; 2001 Nov; 104(3):341-8. PubMed ID: 11722649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient lewis rats and Balb/c mice.
    DeCicco KL; Ross AC
    Proc Nutr Soc; 2000 Nov; 59(4):519-29. PubMed ID: 11115786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid and polyriboinosinic acid act synergistically to enhance the antibody response to tetanus toxoid during vitamin A deficiency: possible involvement of interleukin-2 receptor-beta, signal transducer and activator of transcription-1, and interferon regulatory factor-1.
    DeCicco KL; Zolfaghari R; Li Nq; Ross AC
    J Infect Dis; 2000 Sep; 182 Suppl 1():S29-36. PubMed ID: 10944482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations.
    Ma Y; Chen Q; Ross AC
    J Immunol; 2005 Jun; 174(12):7961-9. PubMed ID: 15944302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.
    Ma Y; Ross AC
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13556-61. PubMed ID: 16157890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vitamin A and retinoic acid supplementation stimulates antibody production and splenic Stra6 expression in tetanus toxoid-immunized mice.
    Tan L; Wray AE; Ross AC
    J Nutr; 2012 Aug; 142(8):1590-5. PubMed ID: 22739370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity.
    Trumpfheller C; Longhi MP; Caskey M; Idoyaga J; Bozzacco L; Keler T; Schlesinger SJ; Steinman RM
    J Intern Med; 2012 Feb; 271(2):183-92. PubMed ID: 22126373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine.
    He LZ; Weidlick J; Sisson C; Marsh HC; Keler T
    Cell Mol Immunol; 2015 Nov; 12(6):719-28. PubMed ID: 25345808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.
    Kumaki Y; Day CW; Bailey KW; Wandersee MK; Wong MH; Madsen JR; Madsen JS; Nelson NM; Hoopes JD; Woolcott JD; McLean TZ; Blatt LM; Salazar AM; Smee DF; Barnard DL
    Antivir Chem Chemother; 2010 Mar; 20(4):169-77. PubMed ID: 20231782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor response to interferon inducer and radiation effect of serum interferon levels.
    Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
    J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of interferon induction by poly ICLC in humans.
    Bever CT; McFarland HF; McFarlin DE; Levy HB
    J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response.
    Ma Y; Ross AC
    Clin Vaccine Immunol; 2009 Oct; 16(10):1476-84. PubMed ID: 19692622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
    Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo.
    Chen Q; Mosovsky KL; Ross AC
    Clin Vaccine Immunol; 2011 Jun; 18(6):1015-20. PubMed ID: 21471300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of interferon responses to poly ICLC in males and females.
    Bever CT; McFarlin DE; Levy HB
    J Interferon Res; 1992 May; Spec No():85-90. PubMed ID: 1379290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.
    Iwata M; Eshima Y; Kagechika H
    Int Immunol; 2003 Aug; 15(8):1017-25. PubMed ID: 12882839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid stimulates IL-2-mediated proliferation of human T lymphocytes: early induction of cyclin D3.
    Engedal N; Gjevik T; Blomhoff R; Blomhoff HK
    J Immunol; 2006 Sep; 177(5):2851-61. PubMed ID: 16920920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.
    Levy HB; Riley FL; Lvovsky E; Stephen EE
    Infect Immun; 1981 Nov; 34(2):416-21. PubMed ID: 6171519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.
    Dillon PM; Petroni GR; Smolkin ME; Brenin DR; Chianese-Bullock KA; Smith KT; Olson WC; Fanous IS; Nail CJ; Brenin CM; Hall EH; Slingluff CL
    J Immunother Cancer; 2017 Nov; 5(1):92. PubMed ID: 29157306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.